Actavis Launches Generic Keppra XR Tablets in the U.S.
Actavis Launches Generic Keppra XR Tablets in the U.S. PR Newswire MORRISTOWN, N.J., Sept. […]
Actavis Launches Generic Keppra XR Tablets in the U.S. PR Newswire MORRISTOWN, N.J., Sept. […]
A leading provider of video and audio conferencing equipment and related network infrastructure, Polycom, Inc. ( PLCM ) recently partnered with a reputed social business solution provider, Jive Software to combine its popular HD video communication service with the latter’s other business solutions in order to provide value-added service to the Jive customers. Presently, large organizations are increasingly implementing different social interactive services like Facebook, Twitter and Youtube to enhance customer relation as well as for retaining customers […]
TRW Automotive Holdings Corp. ( TRW ) recently announced a host of investment plans in order to support its long-term business growth. […]
[thestreet 1161418492001] UBS, Groupon: Hot Trends […]
[marketwatch F3966720-B9FC-4080-B4EB-F8C10A17AF78] Consumer Prices Higher in August […]
[marketwatch 313380D2-BB04-4717-AE41-8A70BE450267] Corporate Succession Plans: Who Makes the Grade? […]
[marketwatch D3EB3B54-2A36-4074-AABD-1CF11B9919F9] Obama: I’m Not Touching Social Security […]
Omnicell, Inc. ’s ( OMCL ) MACD indicator has entered into bullish territory with a reading of 0.1344. The Zacks #2 Rank (“Buy”) stock increased slightly to $16.04 in afternoon trade. […]
Altair ProductDesign Partners with Studio X-GENE to Develop a New Electric Vehicle Concept Car Altair’s ProductDesign division lends its crash, durability, vibration and vehicle dynamics simulation expertise to develop an innovative, lightweight, environmentally friendly vehicle PR Newswire TROY, Mich., Sept. 15, 2011 TROY, Mich. , Sept […]
PetSmart, Inc. ’s ( PETM ) MACD indicator has entered into bullish territory with a reading of 0.4103. The Zacks #2 Rank (“Buy”) stock increased slightly to $44.64 in morning trade. […]
HSN, Inc. ’s ( HSNI ) MACD indicator has entered into bullish territory with a reading of 0.2730. The Zacks #2 Rank (“Buy”) stock increased slightly to $33.57 in morning trade […]
Cracker Barrel Old Country Store Inc . ( CBRL ) reported fourth quarter 2011 a djusted earnings of 99 cents per share, beating the Zacks Consensus Estimate of 90 cents. Quarterly earnings exclude a charge of 25 cents related to organizationa l changes and a new bank facility. […]
[marketwatch 7028B775-6615-4258-91F8-2E09DA2816E7] Euro Banks See Increased Lending Risks […]
Recently, Walgreen ( WAG ) was ranked 29 th among the top 30 technology innovators in the U.S, according to the 2011 InformationWeek 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. […]
[marketwatch 0636AB84-82AC-407E-B32C-630DF9743172] Pop Goes the IPO […]
Cellfish Acquires Bandsintown, the Leading Live Concert Tracking and Discovery Application on Facebook PR Newswire NEW YORK and SAN DIEGO, Sept. 15, 2011 NEW YORK and SAN DIEGO , Sept. 15, 2011 /PRNewswire/ — Cellfish , a leading mobile and social application publisher, today announced its acquisition of Bandsintown , the #1 live concert tracking and discovery application on Facebook, and ranked in the site’s top 5 music apps by monthly average users (MAU), along with Root Music, ReverbNation, Pandora, and Vevo for Artists […]
Nippon Telegraph & Telephone Corp. (ADR) ’s ( NTT ) MACD indicator has entered into bullish territory with a reading of 0.0185. […]
Sustainable Shower Wins $690,000 USD in Postcode Lottery Green Challenge (1) PR Newswire AMSTERDAM, Sept. 15, 2011 AMSTERDAM , Sept. 15, 2011 /PRNewswire-USNewswire/ — Nick Christy of Australia has won the Postcode Lottery Green Challenge 2011 for his Water Recycling Shower […]
US chemical giant EI DuPont de Nemours & Co. ( DD ) has won a civil lawsuit for $919.9 million in the U.S. […]
Novo Nordisk ( NVO ) recently presented data from two trials of its lead diabetes drug, Victoza, at the European Association for the Study of Diabetes (EASD). The first trial showed that using Victoza at an early stage in diabetes treatment of patients with type II diabetes, who had not received any treatment before or previously received only one oral anti-diabetic drug (OAD), led to greater improvements in glycaemic control than those who had been dosed two or more OAD’s. The second trial showed that when type II diabetes patients switched from oral treatment with Merck ’s ( MRK ) Januvia to injectable Victoza (once daily) experienced increased treatment satisfaction as well as significant reductions in blood glucose and body weight […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes